Dryden McKay was the Minnesota State goaltender and winner of the Hobey Baker Award for the NCAA's best player. According to the United States Anti-Doping Agency he has been suspended from competition for six-months due to anti-doping rule violations.
McKay accepted the sanction and the period of ineligibility started on April 14. McKay was in his last NCAA game for the Mavericks, losing 5-1 to Denver in the Frozen Four national champion game.
McKay stated that “This experience was a very unexpected, difficult matter for my family,” in a statement. “I remain positive and look forward starting my professional career in the fall.
McKay told ESPN that he was notified on Feb. 1 that a urine sample collected on Jan. 23 returned a positive test for Ostarine, a muscle growth drug that's not approved by the FDA and considered a banned substance by the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic & Paralympic Committee National Anti-Doping Policy, and the International Ice Hockey Federation Anti-Doping Regulations.
McKay claimed that this amount did not have any direct performance benefits.
The drug testing was underway for McKay, a 24-year-old goalie who had been selected as an alternate player for U.S. Olympic hockey team 2022 for the Beijing Games. McKay's services were not required.
McKay believed that the Ostarine could be sourced from one his supplements. He sent them all to a laboratory for testing. He claimed Ostarine was in an “all-natural” Vitamin D3 immune boost he took for 10 days during COVID-19 Omicron variant surge.
USADA received information from a WADA accredited laboratory during its investigation of the facts of the case. It found that McKay had used a supplement product prior to sample collection that did not contain Ostarine. The label on the Supplement Facts label did not mention Ostarine. This result was consistent with McKay’s circumstances of ingestion and his positive tests. USADA stated in its ruling that the Code allows for a significant decrease in the otherwise applicable ineligibility period in this situation.
McKay being able to determine the source of the contamination, McKay was granted an arbitrator's lifting of his suspension on February 3. This allowed USADA to make a final determination. The NCAA and Minnesota State athletics were informed of the situation. McKay was allowed to finish his senior season with the Mavericks. This led to their first Division I men’s hockey Frozen Four championship appearance.
McKay said, “I knew that (the ruling) would be after the season, just based on the timeline.”
After setting NCAA records of 37 wins and 34 shutouts, he was awarded the Hobey Baker Award.
On the advice of Paul Greene, his lawyer, he accepted the six-month suspension.
Greene stated that “typically the range (for non-intentional intake) is between four to eight months or four to 10 months, depending upon the situation.” “They offered him six month, which is comparable to a lot of other cases I've been involved in. He could choose to accept six months of probation or to go ahead to a hearing. We all agreed that the six-month ban was most appropriate. We are now ready to begin the process, since his season was finished.
McKay had made it clear that he wanted to go pro after this NCAA season. McKay was not selected in the NHL Draft, and is now a free agent. During the Frozen Four, he stated to ESPN that he was only 5'11” and that NHL teams didn't want him. This is a time when physical goalies are preferred. His timeline for his first professional season is further complicated by the USADA ruling.
McKay stated, “I'm still trying (my future) out. And hopefully soon.” McKay said, “Oct. 11 would be the next game I could play, and I can practice in August.”